Stock Research: KORU Medical Systems

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

KORU Medical Systems

NasdaqCM:KRMD US7599101026
78
  • Value
    37
  • Growth
    99
  • Safety
    Safety
    19
  • Combined
    67
  • Sentiment
    62
  • 360° View
    360° View
    78
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

KORU Medical Systems, Inc. is a medical technology company focused on patient-centric large volume subcutaneous infusion solutions for drug delivery. Its main business is mechanical infusion products, including the FREEDOM Infusion Systems. In the last fiscal year, the company had a market cap of $138 million, profits of $21 million, revenue of $34 million, and 80 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 78 (better than 78% compared with alternatives) for 2024, overall professional sentiment and financial characteristics for the stock KORU Medical Systems are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for KORU Medical Systems. The consolidated Growth Rank has a good rank of 99, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 99% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 62, which means that professional investors are more optimistic about the stock than for 62% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 19, which means that the share price of KORU Medical Systems is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 81% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 37, which means that the company has a financing structure that is riskier than those of 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 25 40 43
Growth
99 100 59 31
Safety
Safety
37 37 65 65
Sentiment
62 60 51 41
360° View
360° View
78 78 81 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
44 38 61 8
Opinions Change
50 50 50 50
Pro Holdings
n/a 48 1 51
Market Pulse
67 85 85 70
Sentiment
62 60 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
19 25 40 43
Growth
99 100 59 31
Safety Safety
37 37 65 65
Combined
67 67 9 9
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
52 52 52 52
Price vs. Earnings (P/E)
31 31 51 45
Price vs. Book (P/B)
11 18 48 48
Dividend Yield
1 1 1 1
Value
19 25 40 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
84 66 59 57
Profit Growth
94 94 51 1
Capital Growth
63 100 91 69
Stock Returns
87 100 31 37
Growth
99 100 59 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
78 87 76 83
Refinancing
21 20 43 63
Liquidity
21 21 49 49
Safety Safety
37 37 65 65

Similar Stocks

Discover high‑ranked alternatives to KORU Medical Systems and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.